More J-Pharma Co.,Ltd. news
J-Pharma Co.,Ltd.TSE: 520A

Notice of Grant approval and Commencement of the Grant-Funded Project under AMED’s GRiT Program

Oct 30, 2026 at 2:30 AM EDT · Issued by J-Pharma Co.,Ltd. via TDnet

Filed with TSE · Oct 30, 2026 at 2:30 AM EDT

On 6ix: 6ix.com/news/notice-of-grant-approval-and-commencement-of-the-grant-funded-project-under-ameds-grit-program

J-Pharma Co.,Ltd.

View Attachment

6ix is reading this filing.

View original source (TDnet)J-Pharma Co.,Ltd. on 6ix

Earlier from J-Pharma Co.,Ltd

  • J-Pharma Selected for Funding under AMED's Global Research and Development Support Project for the Treatment of Intractable/Rare DiseasesOct 4
  • J-Pharma Enters into Non-Binding Term Sheet with European Biotech Company for JPH034Sep 24
  • Non-consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)Aug 12
  • Notice Regarding Issuance of New Shares as Restricted Stock Compensation to Directors and Executive OfficersJul 13
  • Matters Relating to Business Plans and Growth PotentialJun 26
All J-Pharma Co.,Ltd news releases↗

Follow J-Pharma Co.,Ltd into a list and get an email when it puts out news.

Follow J-Pharma Co.,Ltd
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer